Nova bioprofile flex 2 operational parts and components for three currently owned nova bioprofile flex 2 instruments due to continuing work on upstream biomanufacturing research.
Active Purchase Order Awarded
- Contract number
- 75F40126P00197
- Awardee
-
Nova Biomedical Corp UEI LCFDHTGXB5J3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $131,322
Award facts
- Contract value 100% obligated
- $131,322.00 Current and potential, with all options
- Completion date 10% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Nova Biomedical Corp for $131,322.00 on September 11, 2026 to procure operational parts and components for three currently owned Nova BioProfile Flex 2 instruments supporting upstream biomanufacturing research. No set-aside applies. Place of performance is Silver Spring, Maryland. The order carries firm fixed price terms with ultimate completion targeted for September 10, 2027.
Quick answers
Who was awarded contract 75F40126P00197?
75F40126P00197 was awarded to Nova Biomedical Corp by Food and Drug Administration (Department of Health and Human Services) on September 11, 2026.
How much is contract 75F40126P00197 worth?
The government has obligated $131,322 on 75F40126P00197.
Was contract 75F40126P00197 competed?
The extent of competition for 75F40126P00197 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award